Internal jugular vein thrombosis as first sign of metastatic lung cancer

Tumori

Volumn 89, Issue 4, 2003, Pages 448-451

  Di Micco, Pierpaolo ^a   Coppola, Leonardo ^a   Diadema, Maria Rosaria ^a   Chirico, Giuseppe ^a   Torella, Roberto ^a   Niglio, Alferio ^a  

^a NONE

Author keywords

Acquired thrombophilia; Deep venous thrombosis; Hypercoagulable state; Lung cancer; Protein S; Spontaneous internal jugular vein thrombosis

Indexed keywords

ANTICOAGULANT AGENT; CISPLATIN; GEMCITABINE; HEPARIN; PROTEIN S; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; HYPERCOAGULABILITY; JUGULAR VEIN; LUNG CARCINOMA; MALE; NECK PAIN; PROTHROMBIN TIME; THROMBOPHILIA; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 0142137157     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160308900421     Document Type: Article

References (28)

1. nd ed, pp 654-712, JB Bailliere et fils, Paris, 1865.
2. Gouin-Thibault I, Achkar A, Samama MM: The thrombophilic state in cancer patients. Acta Haematol, 106: 33-42, 2001.
3. Di Micco P, De Lucia D, De Vita F, Niglio A, Di Micco G, Martinelli E, Chirico G, D'Uva M, Torella R: Acquired cancer-related thrombophilia testified by increased levels of prothrombin fragment 1+2 and d-dimer in patients affected by solid tumors. Exp Oncol, 24: 108-111, 2002.
4. Donati MB: Cancer metastasis: a model of cell-protease and cell-cell interactions. Haemostasis, 31 (suppl): 52-54, 2001.
5. De Lucia D, De Vita F, Orditura M, Renis V, Belli A, Conte M, di Grazia M, Iacoviello L, Donati MB, Catalano G: Hypercoagulable state in patients with advanced gastrointestinal cancer: evidence for an acquired resistance to activated protein C. Tumori, 83: 948-952, 1997.
6. Rickles FR, Levine MN: Epidemiology of thrombosis in cancer. Acta Haematol, 106: 6-12, 2001.
7. Falanga A: Tumor cell prothrombotic properties. Haemostasis, 31 (suppl 1): 1-4, 2001.
8. Piccioli A, Prandoni P: Venous thromboembolism as first manifestation of cancer. Acta Haematol, 106: 13-17, 2001.
9. Balbarini A, Rugolotto M, Buttitta F, Mariotti R, Strata G, Mariani M: Deep venous thrombosis: epidemiologic, diagnostic and therapeutic aspects. Cardiologia, 43: 605-615, 1998.
10. Prandoni P, Bernardi E: Upper extremities deep vein thrombosis. Curr Opin Pulm Med, 5: 222-226, 1999.
11. Schanzer A, Rockman CB, Jacobowitz GR, Riles TS: Internal jugular vein thrombosis in association with the ovarian hyperstimulation syndrome. J Vasc Surg, 31: 815-818, 2000.
12. Sanz Gonzalo JJ, Alobid I, Martinez Molina P, Arias Guchi G, Ruiz A, Cuchi A: Jugular vein thrombosis: report of six cases. Acta Otorrinolaringol Esp, 52: 432-436, 2001.
13. Turay UY, Erdogan Y, Ergun P, Biber C, Ciftci B, Ayaz A: Lemierre's syndrome. Respirology, 6: 171-173, 2001.
14. Van den Noortgate; Michielsen W, Aschrift M, Van Belle S: Spontaneous internal jugular vein thrombosis: primary manifestation of a colorectal cancer in a very old woman. Acta Clin Belg, 55: 94-96, 2000.
15. Chowdhury K, Bloom J, Black MJ, al-Noury K: Spontaneous and non spontaneous internal jugular vein thrombosis. Head Neck, 12: 168-173, 1990.
16. Monreal M, Davant E: Thrombotic complications of central venous catheters in cancer patients. Acta Haematol, 106: 69-72, 2001.
17. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE: A population-based perspective of the hospital incidence and casefatality rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med, 151: 933-938, 1991.
18. Levine MN: Management of venous thrombosis in cancer. Recent developments in diagnosis, prevention and treatment. Tumori, 87 (suppl): 24-26, 2001.
19. Gore JM, Appelbaum JS, Greene HL, Dexter L, Dalen JE: Occult cancer in patients with acute pulmonary embolism. Ann Intern Med, 96: 556-560, 1982.
20. Goldberg RJ, Seneff M, Gore JM, Anderson FA Jr, Greene HL, Wheeler HB, Dalen JE: Occult malignant neoplasm in patients with deep vein thrombosis. Arch Intern Med, 147: 251-253, 1987.
21. Aderka D, Brown A, Zelikowsky A, Pinkhas J: Idiopathic deep vein thrombosis in apparently healthy subject as a premonitory sign of occult cancer. Cancer, 57: 1846-1849, 1986.
22. Prandoni P, Lensing AW, Buller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S, Noventa F, ten Cate JW: Deep vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med, 327: 1128-1133, 1992.
23. Monreal M, Lafoz E, Casals A, Inaraja L, Montserrat E, Callejas JM, Martorell A: Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer, 67: 541-545, 1991.
24. Bastounis EA, Karayannakis AJ, Makri GG, Alexiou D, Papalambros EL: The incidence of occult cancer in patients with deep vein thrombosis: a prospective study. J Intern Med, 239: 153-156, 1996.
25. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA: Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore), 78: 285-291, 1999.
26. Jones MP, Alving B: Laboratory testing for hypercoagulable disorders. Curr Opin Hematol, 3: 365-371, 1996.
27. Kemkes-Matthes B, Plusczyck T, Lasch HG: Coagulation inhibitors in pulmonary cancer patients. Thromb Res, 65: 85-94, 1992.
28. Wimmel A, Rohner I, Ramaswamy A, Heidtmann HH, Seitz R, Kraus M, Schuermann M: Synthesis and secretion of the anticoagulant protein S and coexpression of Tyro3 receptor in human lung carcinoma cells. Cancer, 86: 43-49, 1999.